Letter by Zhang Et Al Regarding Article, "hypotension During Endovascular Treatment of Ischemic Stroke is A Risk Factor for Poor Neurological Outcome"

Jun Zhang,Xiao Zhang,Gelin Xu

DOI: https://doi.org/10.1161/strokeaha.115.010998

IF: 10.17

2015-01-01

Stroke

Abstract:HomeStrokeVol. 46, No. 11Response to Letter Regarding Article, "Hypotension During Endovascular Treatment of Ischemic Stroke Is a Risk Factor for Poor Neurological Outcome" Free AccessLetterPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessLetterPDF/EPUBResponse to Letter Regarding Article, "Hypotension During Endovascular Treatment of Ischemic Stroke Is a Risk Factor for Poor Neurological Outcome" Pia Löwhagen Hendén, MD Pia Löwhagen HendénPia Löwhagen Hendén Department of Anaesthesiology and Intensive Care Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden Originally published1 Oct 2015https://doi.org/10.1161/STROKEAHA.115.011032Stroke. 2015;46:e238Other version(s) of this articleYou are viewing the most recent version of this article. Previous versions: January 1, 2015: Previous Version 1 We appreciate the comments from Drs Zhang, Zhang, and Xu1 and their interest in our recent article,2 in which we demonstrated that intraprocedural hypotension is an independent predictor for poor neurological outcome in patients with acute ischemic stroke undergoing endovascular therapy in general anesthesia (GA). They suggest that other factors than hypotension, for example, increases in central venous pressure, induced by GA and endotracheal intubation, could contribute to impaired cerebral perfusion pressure during the procedure. We are not aware of any reported data on the effects of GA on central venous pressure during this procedure. It has been shown in healthy volunteers, however, that GA with sevoflurane or isoflurane and controlled ventilation, if anything, decreases central venous pressure in addition to the hypotensive effect of these volatile anaesthetics.3 We therefore think that it is less likely that central venous pressure increases during GA for endovascular therapy in acute ischemic stroke.We agree with Zhang et al that 1 major disadvantage with GA for this procedure is the difficulty to monitor neurological deterioration, but we do not agree that the poor outcome was associated with higher age or more comorbidity. There were no significant differences between the good and the poor outcome groups with respect to age and incidences of hypertension, atrial fibrillation, ischemic heart disease, diabetes mellitus, smoking, hyperlipidemia, or obesity. Indeed, National Institutes of Health Stroke Scale on admission was significantly higher in the poor outcome group and National Institutes of Health Stroke Scale was also an independent predictor of poor outcome (modified Rankin Scale score>2) with an odds ratio of 1.17 (95% confidence interval, 1.04–1.33; P=0.012). Importantly, however, when you adjust for differences in National Institutes of Health Stroke Scale, hypotension during the procedure could independently predict poor outcome with an odds ratio of 2.74 (95% confidence interval, 1.04–7.20). Thus, our data, albeit retrospective with all its limitations, strongly support the negative impact of intraprocedural hypotension for poor neurological outcome in endovascular therapy for ischemic stroke. In an attempt to clarify which of the 2 techniques, GA or continuous sedation, is preferable to the other, we are performing a prospective randomized trial comparing GA versus continuous sedation for patients with acute ischemic stroke undergoing endovascular therapy (AnStroke, ClinicalTrials.gov Identifier: NCTO1872884).Pia Löwhagen Hendén, MDDepartment of Anaesthesiology and Intensive Care MedicineSahlgrenska University HospitalGothenburg, SwedenDisclosuresNone.FootnotesStroke welcomes Letters to the Editor and will publish them, if suitable, as space permits. Letters must reference a Stroke published-ahead-of-print article or an article printed within the past 3 weeks. The maximum length is 750 words including no more than 5 references and 3 authors. Please submit letters typed double-spaced. Letters may be shortened or edited. References 1. Zhang J, Zhang X, Xu G.Letter by Zhang et al regarding article, "Hypotension during endovascular treatment of ischemic stroke is a risk factor for poor neurological outcome." Stroke. 2015; 46:e237. doi: 10.1161/STROKEAHA.115.010998.LinkGoogle Scholar2. Löwhagen Hendén P, Rentzos A, Karlsson JE, Rosengren L, Sundeman H, Reinsfelt B, et al. Hypotension during endovascular treatment of ischemic stroke is a risk factor for poor neurological outcome.Stroke. 2015; 46:2678–2680. doi: 10.1161/STROKEAHA.115.009808.LinkGoogle Scholar3. Malan TP, DiNardo JA, Isner RJ, Frink EJ, Goldberg M, Fenster PE, et al. Cardiovascular effects of sevoflurane compared with those of isoflurane in volunteers.Anesthesiology. 1995; 83:918–928.CrossrefMedlineGoogle Scholar Previous Back to top Next FiguresReferencesRelatedDetailsCited By Ahnstedt H, McCullough L and Cipolla M (2016) The Importance of Considering Sex Differences in Translational Stroke Research, Translational Stroke Research, 10.1007/s12975-016-0450-1, 7:4, (261-273), Online publication date: 1-Aug-2016. November 2015Vol 46, Issue 11 Advertisement Article InformationMetrics © 2015 American Heart Association, Inc.https://doi.org/10.1161/STROKEAHA.115.011032PMID: 26429994 Originally publishedOctober 1, 2015 PDF download Advertisement SubjectsCardiopulmonary Resuscitation and Emergency Cardiac CareCerebrovascular ProceduresIschemic Stroke